ImmunoGen’s Mirvetuximab Confidence Justified With Ovarian Cancer Win

Success Follows Accelerated Approval Setback In 2019

Happy Woman traveler over mountains raised hands
Phase III success was achieved in folate receptor alpha-high ovarian cancer • Source: Alamy

More from Clinical Trials

More from R&D